• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Pharmaceutical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Special Issue
Issue Issue 1
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
viyanchi, A., Ghatari, A., Rasekh, H., Safi-khani, H. (2016). Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model. Iranian Journal of Pharmaceutical Research, 15(1), 369-381. doi: 10.22037/ijpr.2016.1800
amir viyanchi; Ali Rajabzadeh Ghatari; Hamid Reza Rasekh; Hamid Reza Safi-khani. "Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model". Iranian Journal of Pharmaceutical Research, 15, 1, 2016, 369-381. doi: 10.22037/ijpr.2016.1800
viyanchi, A., Ghatari, A., Rasekh, H., Safi-khani, H. (2016). 'Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model', Iranian Journal of Pharmaceutical Research, 15(1), pp. 369-381. doi: 10.22037/ijpr.2016.1800
viyanchi, A., Ghatari, A., Rasekh, H., Safi-khani, H. Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model. Iranian Journal of Pharmaceutical Research, 2016; 15(1): 369-381. doi: 10.22037/ijpr.2016.1800

Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model

Article 36, Volume 15, Issue 1, Winter 2016, Page 369-381  XML PDF (1.31 MB)
Document Type: Research article
DOI: 10.22037/ijpr.2016.1800
Authors
amir viyanchi email 1; Ali Rajabzadeh Ghatari2; Hamid Reza Rasekh3; Hamid Reza Safi-khani4
1Shahid Beheshti University of Medical Scineces,Tehran,Iran.
2Tarbiat Modares University
3Shahid Beheshti university of medical sciences
4Member of Strategic Council at National Research Network for Policy Making, Economics & Health Management
Abstract
The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.
The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first questionnaire: evaluation of evidences quality, clinical evaluation, economic evaluation, and managerial appraisal. The 85 experts (purposed sampling) were asked to mark the importance of each criterion from 1 to 100 as 1 representing the least and 100 the most important criterion and 45 out of them replied completely. Then, in the next questionnaire, we evaluated the 48 remainder criteria by the same45 participants under four sub-criteria (Cost calculation simplicity, Interpretability, Precision, and Updating capability of a criterion). After collecting the replies, the remainder criteria were ranked by TOPSIS method. Softwares “SPSS” 17 and Excel 2007 were used.
The ranks of the five most important criteria which were found for drug approval based on TOPSIS are as follows: 1-domestic production (0.556), 2-duration of using (0.399), 3-independence of the assessment group (0.363) 4-impact budgeting (0.362) 5-decisions of other countries about the same drug (0.358). The numbers in parenthesis are relative closeness alternatives in relation to the ideal solution. This model gave a scientific model for judging fairly on the acceptance of novelty medicines.
Keywords
Health Insurance; Criteria Reimbursement; Decision Making; Iran
Main Subjects
Pharmacutics
Statistics
Article View: 9,196
PDF Download: 35,373
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.